Evidence map›Paper›PMID 31788265›Full record

ArticleClinical case reports2019

Infliximab-induced autoimmune hepatitis requiring liver transplantation.

Frederick Wong, Bashaar Al Ibrahim, Joanna Walsh, Karim Qumosani

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. The Role of Novel Immunomodulators in the Treatment of Autoimmune Hepatitis.Journal of clinical and translational hepatology · 2025
    Review
  3. Article
  4. Review
  5. Ustekinumab-induced autoimmune hepatitis: a case report.The Pan African medical journal · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Frederick WongDivision of Gastroenterology Department of Internal Medicine Western University London Ontario Canada.ORCID https://orcid.org/0000-0002-7799-6083
Bashaar Al IbrahimDivision of Gastroenterology Department of Internal Medicine Western University London Ontario Canada.
Joanna WalshDepartment of Pathology and Laboratory Medicine Western University London Ontario Canada.
Karim QumosaniDivision of Gastroenterology Department of Internal Medicine Western University London Ontario Canada.
Western University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and trial of prednisone. We present a rare case of infliximab-induced autoimmune hepatitis leading to liver failure requiring transplantation.

Indexed as

autoimmune hepatitisCrohn's diseaseinfliximabliver transplantation

Identifiers

PMID31788265
PMCPMC6878066
OpenAlexW2976076796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.